First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 3.94 CAD -4.83% Market Closed
Updated: May 20, 2024

HLS Therapeutics Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HLS Therapeutics Inc
Cost of Revenue Peer Comparison

Comparables:
M
MNX

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Cost of Revenue
-$8m
CAGR 3-Years
-31%
CAGR 5-Years
-27%
CAGR 10-Years
18%
M
Manitex Capital Inc
XTSX:MNX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is HLS Therapeutics Inc's Cost of Revenue?
Cost of Revenue
-8m USD

Based on the financial report for Mar 31, 2024, HLS Therapeutics Inc's Cost of Revenue amounts to -8m USD.

What is HLS Therapeutics Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
18%

Over the last year, the Cost of Revenue growth was -45%. The average annual Cost of Revenue growth rates for HLS Therapeutics Inc have been -31% over the past three years , -27% over the past five years , and 18% over the past ten years .